FILE:DVA/DVA-8K-20030619151041.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
 
 
 
 
 
 
 
 
 
 
 
Item 5.    Other Events and Regulation FD Disclosure
 
The Registrant announced today that its wholly-owned subsidiary, Renal Treatment Centers, Inc. ("RTC"), issued a notice of redemption with respect to all of its outstanding 5 5/8% Convertible Subordinated Notes due 2006 (the "Notes"). Attached hereto as Exhibit 99.1 is a press release announcing the redemption of the Notes by RTC issued on June 19, 2003, which is incorporated by reference herein.
 
Item 7.    Financial Statements and Exhibits.
 
(c)  Exhibits
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

EXHIBIT 99.1
 
 
 
 
TORRANCE, CA, June 19, 2003  DaVita Inc. (NYSE: DVA) today announced that Renal Treatment Centers, Inc., its wholly-owned subsidiary, is calling for redemption of its 5
 5
/
8
% Convertible Subordinated Notes due 2006 (the "Notes") as of July 15, 2003. The aggregate principal amount outstanding of the Notes is $125 million. The CUSIP number for the Notes is 759671AC4.
 
Prior to 5:00 p.m., Philadelphia time, on July 14, 2003, holders may convert their Notes into shares of DaVita common stock at a price of $25.62 per share. Any Notes not converted on or before 5:00 p.m., Philadelphia time, on July 14, 2003, automatically will be redeemed on July 15, 2003, and no further interest will accrue. Upon redemption, holders will receive a total of $1,016.90 per $1,000 principal amount of Notes.
 
A Notice of Redemption is being sent to all registered holders of the Notes. Copies of the Notice of Redemption may be obtained from JP Morgan Trust Company National Association by calling bondholder inquiry services at 1-800-275-2048.
 
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 33 states, as well as Washington, D.C. As of March 31, 2003, DaVita operates 523 outpatient facilities serving 45,000 patients, including 3,300 patients in 30 centers under management.


